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Abstract
Background: Pulmonary surfactant is a complex mixture of lipids and proteins. Mutations in surfactant protein-C,
surfactant protein-D, and adenosine triphosphate-binding cassette subfamily A member 3 have been related to
surfactant dysfunction and neonatal respiratory failure in full-term babies. Adenosine triphosphate-binding cassette
subfamily A member 3 facilitates the transfer of lipids to lamellar bodies. We report the case of patient with a
homozygous intronic ABCA3 mutation.
Case presentation: We describe a newborn full-term Colombian baby boy who was the son of non-consanguineous
parents of mixed race ancestry (Mestizo), who was delivered with severe respiratory depression. Invasive treatment
was unsuccessful and diagnosis was uncertain. Exons 4 and 5 of the SP-C gene showed heterozygous Thr138Asn
polymorphism and homozygous Asn186Asn polymorphism respectively. At intron 25 at position –98 from exon 26
a homozygous C>T transition mutation was detected in ABCA3 gene.
Conclusions: The clinical presentation and the histopathological findings of this case are consistent with a case
of neonatal respiratory failure due to surfactant deficiency. Analysis of the five coding SP-C exons does not support
surfactant deficiency. An analysis of the mutation IVS25-98 T was performed and a homozygous mutation responsible for
our case’s neonatal respiratory failure was detected. The findings suggest an autosomic recessive pattern of inheritance.
Genetic counseling was provided and the relatives are now informed of the recurrence risks and treatment options.
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Background
Pulmonary surfactant is a complex mixture of lipids,
primarily dipalmitoylphosphatidylcholine, surfactant pro-
teins (SP-A, SP-B, SP-C, and SP-D), and the protein ad-
enosine triphosphate-binding cassette subfamily A
member 3 (ABCA3), produced by type II pneumocytes.
Pulmonary surfactant is essential for lowering surface ten-
sion at the air–liquid interface to prevent end-expiratory
alveolar collapse. Lamellar bodies are dense multilayer
secretory organelles found in pneumocytes II which store
the surfactant [1]. Mutations in SP-C, SP-D, and ABCA3
have been related to surfactant dysfunction and neonatal
respiratory failure (NRF) in full-term babies and intersti-
tial lung disease (ILD) in older children and adults [2].
ABCA3 is a protein expressed predominantly in the
lung, localized to the limiting membrane of lamellar bod-
ies of type II pneumocytes. The ABCA3 protein is codified
by a single gene located in chromosome 16 which consists
of 33 exons [3]. It has been demonstrated that ABCA3 se-
lectively facilitates the transfer of phosphatidylcholine,
sphingomyelin, and cholesterol to lamellar bodies [4].
Autosomic recessive mutations in the ABCA3 gene
have been frequently involved in NRF due to surfactant
deficiency and some forms of ILD in older children.
The majority of these identified mutations are located
in the exons or the immediate intron–exon boundaries.
A recent article identified an intronic ABCA3 mutation
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in one allele and a known disease causing mutation in
the other as responsible for NRF in a full-term newborn
[5]. We report the case of a full-term baby boy with a
homozygous intronic ABCA3 mutation as the cause of
his fatal respiratory disease.
Case presentation
We describe the case of a full-term Colombian newborn
baby boy who was the product of a primigravid mother,
and non-consanguineous parents of mixed race ancestry
(Mestizo). Fetal monitoring at the 37th week gestational
age showed continuous decelerations. A caesarean section
was performed and he was delivered with severe respira-
tory depression. Management with noninvasive positive-
pressure ventilation was started without success. He was
transferred to our intensive care unit and intubation was
performed. An echocardiogram showed moderate pul-
monary hypertension. Chest X-rays showed complete bi-
lateral opacity of both lungs. Initial treatment with
artificial surfactant was offered without success (Fig. 1).
Blood tests showed 38,900 leukocytes with 90 % neutro-
phils, but the results of all the cultures and the C-reactive
protein were negative. A lung biopsy was performed. Right
apical pneumothorax appeared as a complication of the
procedure and was treated with a chest tube. The lung bi-
opsy showed minimal interstitial changes, preserved al-
veolar architecture, hyperplasia of the alveolar epithelium
(pneumocytes type 2) and a thickened septum full of mes-
enchymal immature cells and few inflammatory cells
(some eosinophils, neutrophils, and leukocytes; Fig. 2).
During his hospitalization, his fever persisted; his
leukocytosis was treated with vancomycin and merope-
nem without any bacteriological finding. He died on
day 60 due to respiratory failure and the diagnosis was
still uncertain.
Based on the suspicion of a SP deficiency, the genes
for SP-B and exon 9 for ABCA3 gene were analyzed
without finding any abnormalities. Exon 4 of the SP-C
gene showed the polymorphism Thr138Asn in the het-
erozygous form (ACT/AAT) and exon 5 the Asn186Asn
polymorphism in the homozygous form (AAC/AAC).
Due to the uncertainty of the diagnosis a literature
review was performed and experts were asked for
advice. A search for a specific mutation in the intronic
region of the ABCA3 gene was performed. In intron 25
at position –98 from exon 26 a homozygous C>T tran-
sition mutation was detected. This mutation changes
the intronic sequence, creates a new donor splice site
and leads to aberrant ABCA3 proteins and is the cause
of our patient’s fatal respiratory disease (Fig. 3).
To confirm the mechanism of inheritance of the dis-
ease and to be able to perform proper genetic counsel-
ing, genetic sequencing for the specific gene was done
on both parents and both are carriers of the mutation
IVS25-98 T.
Discussion
The most common presentation of a baby with ABCA3
mutation that leads to NRF is a full-term baby with
moderate to severe respiratory distress and signs of diffuse
lung disease without satisfactory history or laboratory
findings. The disease is often progressive and fatal within
the first 3 months of life even with proper therapy as
occurred in this case [6–14]. Some cases of older children
with ILD and ABCA3 mutations have been reported. Out
of the four reported cases of patients with a IVS25-98 T
mutation in one allele, two died, one of them received a
lung transplant and the other one is still alive but has ILD
(see Table 1) [5, 7–14].
The histopathological findings in patients with NRF due
to surfactant deficiency consist of type II pneumocytes
hyperplasia, interstitial thickening, and prominent foamy
macrophages in the airspaces, often embedded in variable
amounts of proteinaceous material as found in the biopsy
of our case. These findings are the result of an inborn
error disrupting surfactant metabolism and function and
are nonspecific for any of the SP-B, SP-C and ABCA3
mutations. A molecular diagnosis is needed to determine
the specific mutation affecting each case [15, 16].
In exon 4 our patient shows the polymorphism
Thr138Asn in the heterozygous form (ACT/AAT) and
in exon 5 the Asn186Asn polymorphism in the homo-
zygous form (AAC/AAC). These findings have been
associated with risk of perinatal NRF in preterm male
newborns. However, our patient was born at term and
these polymorphisms have been frequently found in
healthy people. Therefore, one may conclude that the
Fig. 1 Anteroposterior chest radiograph from a newborn baby boy
showing bilateral diffuse hazy granular pulmonary opacification
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analysis of the five coding SP-C exons does not sup-
port surfactant deficiency or a fatal malfunction of sur-
factant transport [17].
Definitive diagnosis required examination of DNA for
ABCA3 intronic mutations. The analysis of the mutation
IVS25-98 T was performed and a homozygous mutation
was detected. This intronic mutation has been previously
reported in heterozygous patients with severe NRF. The
genetic analysis of such patients showed one allele with
the intronic mutation and an exonic mutation in the other
one. It is known that the IVS-98 T is a NRF-causing
ABCA3 mutation since the intronic sequence creates a
new donor splice site which leads to aberrantly spliced
transcripts. It is suggested that the additional amino acids
added to the ABCA3 protein alter its intracellular routing,
stability, and function [5]. Recently, intronic mutations
have been found in cystic fibrosis as disease-causing
mutations in patients without a previously identified
exonic mutation [18].
The literature reports four additional cases homozy-
gous for ABCA3 IVS25-98 T. The four babies were un-
related, no history of consanguinity was identified, but
all of them came from South America [5]. Although the
mechanism of inheritance is still unclear and isodisomic
uniparental disomy has been reported for ABCA3 defi-
ciency, we speculate through our findings that the mech-
anism of inheritance could be autosomic recessive and
the ethnical similarities of the cases could suggest a pos-
sible founder effect for this population [6]. Further larger
population-based studies are required to determine the
real frequency of IVS25-98 T in this population.
In spite of the fact that establishing the diagnosis did
not alter the outcome of the patient and usually the
diagnosis is established after the decease of the patient,
it is essential to adequately counsel the parents and family
members of the recurrence risk. Our patient’s parents
were encouraged to have their ABCA3 gene screened for
the IVS25-98 T mutation. Both parents of our patient
are heterozygous carriers of the IVS25-98 T mutation in
the ABCA3 gene. Therefore, children have a chance of
25 % of being affected by lethal ABCA3 deficiency and
50 % of being carriers. Two sisters of our patient’s father
are heterozygous carriers of the IVS25-98 T mutation
in the ABCA3 gene. Their partners do not carry the
Fig. 2 Panels a and b are different plates from the lung biopsy showing pulmonary alveolar proteinosis pattern characterized by type II
pneumocytes hyperplasia, interstitial widening, and fine granular proteinosis material admixed with foamy macrophages
Fig. 3 ABCA3, exon 26 sequence from 45981 to 46336 showing homozygous mutation IVS25 (gttacaggTgccttgag)
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IVS25-98 T mutation, thus children of both couples have
a statistical chance of 25 % of being heterozygous carriers
of the mutation and none of them will be affected.
Conclusions
The clinical presentation of this case is consistent with a
case of NRF due to surfactant deficiency. The histo-
pathological findings in patients with NRF due to surfac-
tant deficiency are nonspecific for any of the SP-B, SP-C
and ABCA3 mutations and a molecular diagnosis is
needed. The analysis of the five coding SP-C exons does
not support surfactant deficiency or a fatal malfunction
of surfactant transport due to SP-C mutations as the
cause for our patient’s symptoms. Without evidence of a
previously identified ABCA3 mutation in an exon or an
immediate intron–exon boundary, we conclude that the
homozygous IVS25-98 T mutation is responsible for this
case’s NRF. The findings of our patient’s relatives suggest
an autosomic recessive pattern of inheritance. Genetic
counseling was provided and the relatives are now in-
formed of the recurrence risks and treatment options.
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